Beli Molecule (MOLECULE) di Mexico

Molecule is a prominent project in the decentralized science (DeSci) space that aims to transform how medical research and drug development are funded and managed. The primary goal of the project is to create a more open, collaborative, and efficient system for scientific discovery, particularly in fields like longevity and biotechnology. It addresses the traditional funding gap known as the Valley of Death, where many early-stage research projects fail to secure the necessary capital to move into clinical trials. The project uses blockchain technology to tokenize scientific intellectual property through a framework involving Intellectual Property Non-Fungible Tokens (IP-NFTs) and Intellectual Property Tokens (IPTs). By creating these on-chain representations of research data and legal rights, Molecule allows scientists to raise funds directly from a global community of investors, patients, and researchers. This model democratizes access to scientific ownership and enables collaborative governance over potential medical breakthroughs. Molecule operates a marketplace called Molecule Discovery, where researchers can list their work to find funding. The ecosystem is supported by several specialized organizations known as BioDAOs, such as VitaDAO, which focuses on longevity, and AthenaDAO, which focuses on women's health. These communities use the Molecule protocol to evaluate research proposals and collectively manage the resulting intellectual property. Recently, the project has expanded its reach with the launch of initiatives like pump.science, a platform on the Solana blockchain designed to facilitate the funding of longevity experiments through community-backed tokens. This expansion emphasizes the project's focus on using bonding curves and simplified user experiences to accelerate scientific progress. While the name Molecule is also associated with a meme coin token on various exchanges, the core Web3 project is centered on these decentralized science initiatives. The protocol is led by a team of scientists, legal experts, and developers who are working to build a global, interoperable system for scientific intellectual property. By aligning the incentives of researchers and funders, Molecule seeks to turn scientific discoveries into real-world treatments more effectively than traditional pharmaceutical models. Pelajari Lebih Lanjut